通过给予磺胺二甲嘧啶确定的衰老与乙酰化酶表型。 - Suppr

Suppr

超能文献

Ageing and acetylator phenotype as determined by administration of sulphadimidine.

作者信息

Pontiroli A E, De Pasqua A, Bonisolli L, Pozza G

出版信息

Eur J Clin Pharmacol. 1985;28(4):485-6. doi: 10.1007/BF00544374.

DOI:10.1007/BF00544374

PMID:4029255

Abstract

摘要

相似文献

Ageing and acetylator phenotype as determined by administration of sulphadimidine.通过给予磺胺二甲嘧啶确定的衰老与乙酰化酶表型。

Eur J Clin Pharmacol. 1985;28(4):485-6. doi: 10.1007/BF00544374.

Effect of concomitant isoniazid administration on determination of acetylator phenotype by sulphadimidine.同时服用异烟肼对用磺胺二甲嘧啶测定乙酰化代谢表型的影响。

Eur J Clin Pharmacol. 1986;30(4):463-6. doi: 10.1007/BF00607961.

Possible optimization of sulphadimidine dosage for acetylator phenotyping.磺胺二甲嘧啶剂量用于乙酰化酶表型分析的可能优化

Jpn J Pharmacol. 1991 Aug;56(4):531-4. doi: 10.1254/jjp.56.531.

Evaluation of the sulphadimidine acetylator phenotyping test in patients with reduced renal function.

Acta Med Scand. 1981;209(6):505-7. doi: 10.1111/j.0954-6820.1981.tb11636.x.

Comparison between serum and urinary sulphadimidine acetylation as predictors of isoniazid acetylator status in patients with pulmonary tuberculosis.肺结核患者血清与尿液中磺胺二甲嘧啶乙酰化作为异烟肼乙酰化状态预测指标的比较

Indian J Chest Dis Allied Sci. 1996 Jan-Mar;38(1):5-11.

N-acetylation phenotyping with sulphadimidine in a Turkish population.

Eur J Clin Pharmacol. 1990;38(1):53-6. doi: 10.1007/BF00314803.

Relationship between acetylator phenotype and intensity of the hypoglycaemic effect of a suplhonamide preparation in children with insulin-dependent diabetes.乙酰化表型与磺酰胺制剂对胰岛素依赖型糖尿病儿童降血糖作用强度之间的关系。

Bratisl Lek Listy. 1991 Dec;92(12):609-14.

Acetylator phenotyping with sulphadimidine in patients receiving isoniazid.接受异烟肼治疗的患者中使用磺胺二甲嘧啶进行乙酰化表型分析。

Int J Clin Pharmacol Res. 1984;4(2):141-4.

Acetylator polymorphism in rheumatoid arthritis.类风湿关节炎中的乙酰化酶多态性

Eur J Clin Pharmacol. 1993;45(3):279-81. doi: 10.1007/BF00315397.

The relationship between the acetylator and the sparteine hydroxylation polymorphisms.乙酰化酶与司巴丁羟基化多态性之间的关系。

J Med Genet. 1986 Apr;23(2):155-6. doi: 10.1136/jmg.23.2.155.

引用本文的文献

Ageing and acetylator phenotype.

Eur J Clin Pharmacol. 1985;29(3):377. doi: 10.1007/BF00544098.

Acetylation and oxidation phenotypes in malignant lymphoma.

Cancer Chemother Pharmacol. 1987;20(3):235-8. doi: 10.1007/BF00570492.

Influence of age, sex and body weight on the dapsone acetylation phenotype.年龄、性别和体重对氨苯砜乙酰化表型的影响。

Br J Clin Pharmacol. 1987 Jun;23(6):709-13. doi: 10.1111/j.1365-2125.1987.tb03105.x.

Hepatic drug metabolism and aging.肝脏药物代谢与衰老

Clin Pharmacokinet. 1990 Nov;19(5):359-89. doi: 10.2165/00003088-199019050-00002.

本文引用的文献

HUMAN ACETYLATION POLYMORPHISM.人类乙酰化多态性

J Lab Clin Med. 1964 Mar;63:394-403.

Determination of the acetylator phenotype and pharmacokinetics of some sulphonamides in man.人体中某些磺胺类药物乙酰化表型及药代动力学的测定

Clin Pharmacokinet. 1980 May-Jun;5(3):274-94. doi: 10.2165/00003088-198005030-00006.

Acetylator phenotypes: effect of age.

Eur J Clin Pharmacol. 1984;26(1):43-5. doi: 10.1007/BF00546707.

Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer.N-乙酰转移酶表型在膀胱癌发生中的作用：一种膀胱癌的药物遗传学流行病学研究方法

Lancet. 1982 Oct 16;2(8303):842-5. doi: 10.1016/s0140-6736(82)90810-8.

An improved and simplified method of detecting the acetylator phenotype.一种检测乙酰化酶表型的改良简化方法。

J Med Genet. 1969 Dec;6(4):405-7. doi: 10.1136/jmg.6.4.405.

Hepatic drug acetylation and oxidation: effects of aging in man.肝脏药物乙酰化和氧化：衰老对人体的影响。

Br Med J. 1977 Jul 16;2(6080):155-6. doi: 10.1136/bmj.2.6080.155.

Diabetic dimorphism according to acetylator status.根据乙酰化状态的糖尿病双态性。

Br Med J. 1978 Jan 28;1(6107):208-10. doi: 10.1136/bmj.1.6107.208.

Disease and acetylation polymorphism.疾病与乙酰化多态性

Clin Pharmacokinet. 1977 May-Jun;2(3):182-97. doi: 10.2165/00003088-197702030-00003.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验